These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 36085125)

  • 1. Efficacy and safety of antipsychotics and antidepressants in the treatment of anorexia nervosa: a systematic review.
    Márquez MC; Sánchez JM; Salazar AM; Martínez CV; Valderrama F; Rojas-Gualdrón DF
    Rev Colomb Psiquiatr (Engl Ed); 2022; 51(3):227-235. PubMed ID: 36085125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and Safety of Antipsychotics and Antidepressants in the Treatment of Anorexia Nervosa: a Systematic Review.
    Márquez MC; Sánchez JM; Salazar AM; Martínez CV; Valderrama F; Rojas-Gualdrón DF
    Rev Colomb Psiquiatr (Engl Ed); 2021 Jan; ():. PubMed ID: 33735059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychotropic drug treatment in anorexia nervosa. Search for differences in efficacy/tolerability between adolescent and mixed-age population.
    Balestrieri M; Oriani MG; Simoncini A; Bellantuono C
    Eur Eat Disord Rev; 2013 Sep; 21(5):361-73. PubMed ID: 23733453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are antipsychotics effective for the treatment of anorexia nervosa? Results from a systematic review and meta-analysis.
    Kishi T; Kafantaris V; Sunday S; Sheridan EM; Correll CU
    J Clin Psychiatry; 2012 Jun; 73(6):e757-66. PubMed ID: 22795216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of eating disorders.
    Aigner M; Treasure J; Kaye W; Kasper S;
    World J Biol Psychiatry; 2011 Sep; 12(6):400-43. PubMed ID: 21961502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological interventions for borderline personality disorder.
    Stoffers J; Völlm BA; Rücker G; Timmer A; Huband N; Lieb K
    Cochrane Database Syst Rev; 2010 Jun; (6):CD005653. PubMed ID: 20556762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antipsychotic effects on anthropometric outcomes in anorexia nervosa: a retrospective chart review of hospitalized children and adolescents.
    Frank B; Arnold S; Jaite C; Correll CU
    J Eat Disord; 2023 Sep; 11(1):151. PubMed ID: 37674209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential weight restoration on olanzapine versus fluoxetine in identical twins with anorexia nervosa.
    Duvvuri V; Cromley T; Klabunde M; Boutelle K; Kaye WH
    Int J Eat Disord; 2012 Mar; 45(2):294-7. PubMed ID: 21344468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inpatient versus outpatient care, partial hospitalisation and waiting list for people with eating disorders.
    Hay PJ; Touyz S; Claudino AM; Lujic S; Smith CA; Madden S
    Cochrane Database Syst Rev; 2019 Jan; 1(1):CD010827. PubMed ID: 30663033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-Dose Olanzapine in the Treatment of Adolescents with Anorexia Nervosa: An Observational Naturalistic Case-Control Study.
    Pruccoli J; Pettenuzzo I; Parmeggiani A
    J Child Adolesc Psychopharmacol; 2022 Jun; 32(5):304-310. PubMed ID: 35612433
    [No Abstract]   [Full Text] [Related]  

  • 11. Olanzapine for young PEople with aNorexia nervosa (OPEN): A protocol for an open-label feasibility study.
    Said O; Sengun Filiz E; Stringer D; Applewhite B; Kellermann V; Mutwalli H; Bektas S; Akkese MN; Kumar A; Carter B; Simic M; Sually D; Bentley J; Young AH; Madden S; Byford S; Landau S; Lawrence V; Treasure J; Schmidt U; Nicholls D; Himmerich H
    Eur Eat Disord Rev; 2024 May; 32(3):532-546. PubMed ID: 38299859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atypical antipsychotics and anorexia nervosa: a review.
    McKnight RF; Park RJ
    Eur Eat Disord Rev; 2010 Jan; 18(1):10-21. PubMed ID: 20054875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of fluoxetine in anorexia nervosa before and after weight restoration.
    Sebaaly JC; Cox S; Hughes CM; Kennedy ML; Garris SS
    Ann Pharmacother; 2013 Sep; 47(9):1201-5. PubMed ID: 24259736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serotonergic and dopaminergic systems in anorexia nervosa: a role for atypical antipsychotics?
    Bosanac P; Norman T; Burrows G; Beumont P
    Aust N Z J Psychiatry; 2005 Mar; 39(3):146-53. PubMed ID: 15701063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychotropic medication use in anorexia nervosa between 1997 and 2009.
    Fazeli PK; Calder GL; Miller KK; Misra M; Lawson EA; Meenaghan E; Lee H; Herzog D; Klibanski A
    Int J Eat Disord; 2012 Dec; 45(8):970-6. PubMed ID: 22733643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychopharmacological options for adult patients with anorexia nervosa.
    Miniati M; Mauri M; Ciberti A; Mariani MG; Marazziti D; Dell'Osso L
    CNS Spectr; 2016 Apr; 21(2):134-42. PubMed ID: 26145463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antidepressants for anorexia nervosa.
    Claudino AM; Hay P; Lima MS; Bacaltchuk J; Schmidt U; Treasure J
    Cochrane Database Syst Rev; 2006 Jan; (1):CD004365. PubMed ID: 16437485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New discoveries for an old drug: a review of recent olanzapine research.
    Meftah AM; Deckler E; Citrome L; Kantrowitz JT
    Postgrad Med; 2020 Jan; 132(1):80-90. PubMed ID: 31813311
    [No Abstract]   [Full Text] [Related]  

  • 19. The pharmacologic treatment of eating disorders.
    Walsh BT; Devlin MJ
    Psychiatr Clin North Am; 1992 Mar; 15(1):149-60. PubMed ID: 1347938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of olanzapine in the treatment of anorexia nervosa.
    Dunican KC; DelDotto D
    Ann Pharmacother; 2007 Jan; 41(1):111-5. PubMed ID: 17190846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.